1. Academic Validation
  2. Residence time and kinetic efficiency analysis of extracellular signal-regulated kinase 2 inhibitors

Residence time and kinetic efficiency analysis of extracellular signal-regulated kinase 2 inhibitors

  • Anal Biochem. 2015 Mar 15:473:46-52. doi: 10.1016/j.ab.2014.12.008.
Darin Vanderpool 1 Charles E Grimshaw 1 J David Lawson 2 Jacques Ermolieff 3
Affiliations

Affiliations

  • 1 Enzymology and Biophysical Chemistry Group, Takeda California, San Diego, CA 92121, USA.
  • 2 Computational Sciences and Crystallography Group, Takeda California, San Diego, CA 92121, USA.
  • 3 Enzymology and Biophysical Chemistry Group, Takeda California, San Diego, CA 92121, USA. Electronic address: [email protected].
Abstract

The Ras/Raf/MEK/ERK signal transduction cascade plays an important role in the regulation of critical cellular processes such as cell proliferation, migration, and differentiation. The up-regulation of this pathway can negatively affect cell homeostasis and is responsible for the development of various forms of Cancer and inflammation processes. Therefore, there is a strong interest in pursuing drug programs targeting some of the enzymes involved in this pathway. In addition to the determination of Ki, Kd, IC50, and/or EC50, a more thorough kinetic analysis can provide useful information for the selection of the best lead series during the early stage of the drug discovery process. This study describes a medium-throughput fluorescent probe displacement assay for the rapid determination of the k(off) constant, residence time, and kinetic efficiency for ERK (extracellular signal-regulated kinase) inhibitors. Using this method, we have identified several inhibitors that we have subjected to further kinetic analysis by comparing k(off) constants determined for these time-dependent inhibitors using either the active or inactive form of ERK2.

Keywords

ERK2; Kinetic efficiency; Off-rate; Residence time; Structure–kinetic relationship; Time-dependent inhibition.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-14178A
    98.08%, ERK2 Inhibitor
    ERK